About Arbor pharma
Arbor pharma is a company based in Atlanta (United States) founded in 2006 was acquired by Azurity Pharmaceuticals in August 2021. Arbor pharma has raised $23.14 million across 7 funding rounds from investors including KKR, Azurity Pharmaceuticals and JW Asset Management. The company has 625 employees as of December 31, 2017. Arbor pharma has completed 1 acquisition, including XenoPort. Arbor pharma offers products and services including Xifyrm and Danziten.
- Headquarter Atlanta, United States
- Employees 625 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Azurity Pharmaceuticals, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23.14 M (USD)
in 7 rounds
-
Latest Funding Round
Not available
-
Investors
KKR
& 4 more
-
Employee Count
625
as on Dec 31, 2017
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Arbor pharma
Arbor pharma offers a comprehensive portfolio of products and services, including Xifyrm and Danziten.
Xifyrm is utilized for the management of moderate-to-severe pain in adults as an IV non-steroidal anti-inflammatory drug.
Danziten is employed in oncology treatments, with full prescribing information provided for indications and safety.
Funding Insights of Arbor pharma
Arbor pharma has successfully raised a total of $23.14M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Arbor pharma
Arbor pharma has secured backing from 5 investors, including venture fund and angel investors. Prominent investors backing the company include KKR, Azurity Pharmaceuticals and JW Asset Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by this private equity firm.
|
Locked | Locked | Locked | |
|
Investment services are offered in healthcare and cannabis sectors.
|
Locked | Locked | Locked | |
|
PE firm investing in North America and Europe
|
Locked | Locked | Locked |
Investor details for Arbor pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Arbor pharma
Arbor pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include XenoPort.
Investment portfolio details for Arbor pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biopharmaceutical products for neurological disorders and pain are provided.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Arbor pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Arbor pharma
Detailed financials for Arbor pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Arbor Pharma Comparisons
Peer comparison for Arbor pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Arbor pharma
Detailed competitors of Arbor pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Arbor Pharma
Complete news archive for Arbor pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arbor pharma
Arbor pharma was founded in 2006.
Arbor pharma is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Arbor pharma is a funded company, having raised a total of $23.14M across 7 funding rounds to date.
As of Dec 31, 2017, the latest employee count at Arbor pharma is 625.
Arbor Pharma was founded in 2006 and is headquartered in Atlanta, United States. Operations are centered in the pharmaceutical sector, where novel dose forms of existing medications are developed to address unmet patient needs. Emphasis is placed on scaled and rapid development, strengthened commercial functions, and a workforce guided by principles of clarity, collaboration, empathy, reliability, and simplicity. High-quality medicines are targeted at underserved populations.
Arbor pharma offers Xifyrm and Danziten.
Arbor pharma has made 1 acquisition, including XenoPort.
Arbor pharma has 5 investors. Key investors include KKR, Azurity Pharmaceuticals, JW Asset Management, Signet Healthcare Partners, and Jason Wild.